Phibro Animal Health (NASDAQ:PAHC) Rating Lowered to Buy at StockNews.com

Phibro Animal Health (NASDAQ:PAHC) was downgraded by StockNews.com from a “strong-buy” rating to a “buy” rating in a note issued to investors on Sunday.

Several other analysts have also issued reports on the company. Morgan Stanley increased their target price on Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a report on Tuesday, December 17th. Barclays increased their price objective on shares of Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a research note on Tuesday, November 12th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $20.50.

Phibro Animal Health Trading Up 1.1 %

Shares of PAHC stock opened at $20.27 on Friday. The stock has a market cap of $821.00 million, a P/E ratio of 47.14, a price-to-earnings-growth ratio of 0.58 and a beta of 0.53. Phibro Animal Health has a 1 year low of $10.03 and a 1 year high of $25.98. The company has a current ratio of 3.23, a quick ratio of 1.69 and a debt-to-equity ratio of 1.81. The stock has a 50 day simple moving average of $22.71 and a 200 day simple moving average of $21.15.

Institutional Trading of Phibro Animal Health

Several large investors have recently bought and sold shares of the business. nVerses Capital LLC bought a new stake in shares of Phibro Animal Health during the third quarter worth $70,000. Quantbot Technologies LP acquired a new stake in shares of Phibro Animal Health during the 3rd quarter valued at $70,000. China Universal Asset Management Co. Ltd. grew its position in Phibro Animal Health by 63.7% during the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock worth $88,000 after acquiring an additional 1,522 shares during the last quarter. CWM LLC increased its holdings in Phibro Animal Health by 190.8% in the 3rd quarter. CWM LLC now owns 6,363 shares of the company’s stock worth $143,000 after purchasing an additional 4,175 shares in the last quarter. Finally, Algert Global LLC bought a new position in Phibro Animal Health in the second quarter valued at about $193,000. 99.34% of the stock is owned by institutional investors and hedge funds.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.